\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ was\\ tachypnic\\ and\\ pale\\.\\ \\ her\\ oxygen\\ saturation\\ was\\ 93\\%\\ on\\ room\\ air\\.\\ \\ lab\\ work\\ showed\\ a\\ hematocrit\\ and\\ hemoglobin\\ of\\ 4\\.5\\ and\\ 15\\.7\\,\\ respectively\\.\\ \\ her\\ coagulation\\ studies\\ were\\ normal\\.\\ \\ blood\\ gas\\ showed\\ a\\ po2\\ of\\ 55\\.\ \(0\)\
\-\ patient\\ was\\ anticoagulated\\ with\\ heparin\\ and\\ coumadin\\ for\\ treatment\\ of\\ her\\ pulmonary\\ embolus\\.\ \(0\)\
\-\ a\\ ct\\ pe\\/dvt\\ protocol\\ was\\ initially\\ performed\\ following\\ transfusion\\ of\\ 3\\ units\\ of\\ blood\\.\\ \\ \\ the\\ study\\ was\\ limited\\ secondary\\ to\\ patient\\â\\€\\™s\\ respiratory\\ motion\\.\\ \\ a\\ questionable\\ filling\\ defect\\ was\\ thought\\ to\\ be\ \(0\)\
\-\ pulmonary\\ embolus\ \(16\)\
\-\ pulmonary\\ embolus\ \(16\)\
\-\ 84\\ year\\ old\\ woman\\ with\\ past\\ medical\\ history\\ significant\\ for\\ depression\\,\\ presented\\ to\\ the\\ pulmonology\\ clinic\\ with\\ 2\\-3\\ month\\ history\\ of\\ fatigue\\ which\\ had\\ increased\\ in\\ the\\ last\\ 2\\-3\\ weeks\\.\\ \\ patient\\ also\\ reported\\ increased\\ difficulty\\ breathing\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ embolus\\:\\ 0\\.11448792839637449\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.06830853043815605\ \(0\)\
\-\ 55\\.\\:\\ 0\\.06530013647382592\ \(0\)\
\-\ 15\\.7\\:\\ 0\\.060165712914122614\ \(0\)\
\-\ her\\:\\ 0\\.057098036855220795\ \(0\)\
\-\ pulmonary\\:\\ 0\\.055478895782668076\ \(0\)\
\-\ tachypnic\\:\\ 0\\.053378374159499246\ \(0\)\
\-\ pulmonology\\:\\ 0\\.05088598722156434\ \(0\)\
\-\ po2\\:\\ 0\\.04989686579471602\ \(0\)\
\-\ 93\\:\\ 0\\.045240505354550285\ \(0\)\
\-\ pe\\/dvt\\:\\ 0\\.045240505354550285\ \(0\)\
\-\ coagulation\\:\\ 0\\.04476244223501272\ \(0\)\
\-\ anticoagulated\\:\\ 0\\.04476244223501272\ \(0\)\
\-\ was\\:\\ 0\\.043923445431719416\ \(0\)\
\-\ 4\\.5\\:\\ 0\\.04274811841661537\ \(0\)\
\-\ transfusion\\:\\ 0\\.04274811841661537\ \(0\)\
\-\ pale\\:\\ 0\\.04207425339286925\ \(0\)\
\-\ showed\\:\\ 0\\.04150819656183254\ \(0\)\
\-\ coumadin\\:\\ 0\\.04010608179484698\ \(0\)\
\-\ 84\\:\\ 0\\.03986319421838039\ \(0\)\
\-\ heparin\\:\\ 0\\.038964224907237666\ \(0\)\
\-\ units\\:\\ 0\\.038964224907237666\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.03855259638016499\ \(0\)\
\-\ saturation\\:\\ 0\\.037269102148505456\ \(0\)\
\-\ hematocrit\\:\\ 0\\.037269102148505456\ \(0\)\
\-\ depression\\:\\ 0\\.03693982983316595\ \(0\)\
\-\ respectively\\:\\ 0\\.03647183796930275\ \(0\)\
\-\ oxygen\\:\\ 0\\.03632218828546927\ \(0\)\
\-\ questionable\\:\\ 0\\.03575210649927573\ \(0\)\
\-\ blood\\:\\ 0\\.03455423811124888\ \(0\)\
\-\ protocol\\:\\ 0\\.03404452384289179\ \(0\)\
\-\ breathing\\:\\ 0\\.03404452384289179\ \(0\)\
\-\ fatigue\\:\\ 0\\.03382980134753436\ \(0\)\
\-\ increased\\:\\ 0\\.030970144915550456\ \(0\)\
\-\ lab\\:\\ 0\\.03096881063508787\ \(0\)\
\-\ gas\\:\\ 0\\.03015249107854258\ \(0\)\
\-\ work\\:\\ 0\\.029654326434030227\ \(0\)\
\-\ thought\\:\\ 0\\.0291312333435565\ \(0\)\
\-\ clinic\\:\\ 0\\.028283749260758394\ \(0\)\
\-\ difficulty\\:\\ 0\\.028184319480520314\ \(0\)\
\-\ room\\:\\ 0\\.027213739758991395\ \(0\)\
\-\ last\\:\\ 0\\.027042462592910994\ \(0\)\
\-\ limited\\:\\ 0\\.026711350156482055\ \(0\)\
\-\ respiratory\\:\\ 0\\.02627896492520867\ \(0\)\
\-\ initially\\:\\ 0\\.02576281736492726\ \(0\)\
\-\ filling\\:\\ 0\\.025483259379869134\ \(0\)\
\-\ motion\\:\\ 0\\.025449044966118807\ \(0\)\
\-\ patient\\:\\ 0\\.025380501656781868\ \(0\)\
\-\ defect\\:\\ 0\\.023694424639258718\ \(0\)\
\-\ studies\\:\\ 0\\.02364074753910489\ \(0\)\
\-\ reported\\:\\ 0\\.023074628522783792\ \(0\)\
\-\ air\\:\\ 0\\.02141676019668123\ \(0\)\
\-\ study\\:\\ 0\\.020826898939703402\ \(0\)\
\-\ past\\:\\ 0\\.020112588681084696\ \(0\)\
\-\ medical\\:\\ 0\\.01947636888937781\ \(0\)\
\-\ month\\:\\ 0\\.018989737339263773\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.018918716589966342\ \(0\)\
\-\ s\\:\\ 0\\.018153834571219163\ \(0\)\
\-\ following\\:\\ 0\\.017965020421489987\ \(0\)\
\-\ weeks\\:\\ 0\\.017965020421489987\ \(0\)\
\-\ secondary\\:\\ 0\\.017696518270435613\ \(0\)\
\-\ performed\\:\\ 0\\.017648728379461624\ \(0\)\
\-\ history\\:\\ 0\\.017484659817882716\ \(0\)\
\-\ presented\\:\\ 0\\.017254501000165994\ \(0\)\
\-\ significant\\:\\ 0\\.01702109000780906\ \(0\)\
\-\ 3\\:\\ 0\\.014822040938566962\ \(0\)\
\-\ \\%\\:\\ 0\\.014765340987748204\ \(0\)\
\-\ woman\\:\\ 0\\.01462150331473264\ \(0\)\
\-\ were\\:\\ 0\\.014372491382888306\ \(0\)\
\-\ had\\:\\ 0\\.013658146809190431\ \(0\)\
\-\ treatment\\:\\ 0\\.01281197747852509\ \(0\)\
\-\ also\\:\\ 0\\.012478663656815936\ \(0\)\
\-\ which\\:\\ 0\\.011815885831426287\ \(0\)\
\-\ a\\:\\ 0\\.011751105239069668\ \(0\)\
\-\ for\\:\\ 0\\.010801602202114298\ \(0\)\
\-\ normal\\:\\ 0\\.0099230552192526\ \(0\)\
\-\ be\\:\\ 0\\.009761160913658735\ \(0\)\
\-\ to\\:\\ 0\\.00949040240984414\ \(0\)\
\-\ ct\\:\\ 0\\.008854101136237356\ \(0\)\
\-\ year\\:\\ 0\\.0070822612538734425\ \(0\)\
\-\ old\\:\\ 0\\.006480997013794479\ \(0\)\
\-\ on\\:\\ 0\\.005362155647151319\ \(0\)\
\-\ and\\:\\ 0\\.00533360016984351\ \(0\)\
\-\ of\\:\\ 0\\.005177946702132819\ \(0\)\
\-\ \\,\\:\\ 0\\.0040105194891449985\ \(0\)\
\-\ in\\:\\ 0\\.0031214609640018887\ \(0\)\
\-\ the\\:\\ 0\\.00307220632674724\ \(0\)\
\-\ with\\:\\ 0\\.00260009280199755\ \(0\)\
\-\ \\.\\:\\ 0\\.002366635739823085\ \(0\)\
